NCT04969848View on ClinicalTrials.gov

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Multiple Sclerosis
Interventions
OTHER

Wearable sensor

IMU sensor (as part of eMSGait device) worn at the hip during T25FW

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT04969848 - Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device | Biotech Hunter | Biotech Hunter